Total Payments
$74,158
2024 Payments
$61,808
Companies
25
Transactions
209
Medicare Patients
1,427
Medicare Billing
$191,738
Payment Breakdown by Category
Other$66,473 (89.6%)
Food & Beverage$5,322 (7.2%)
Travel$2,266 (3.1%)
Education$96.81 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,473 | 28 | 89.6% |
| Food and Beverage | $5,322 | 168 | 7.2% |
| Travel and Lodging | $2,266 | 10 | 3.1% |
| Education | $96.81 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Madrigal Pharmaceuticals | $48,472 | 38 | $0 (2024) |
| ABBVIE INC. | $20,156 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $3,189 | 19 | $0 (2023) |
| Gilead Sciences, Inc. | $486.24 | 24 | $0 (2024) |
| Celgene Corporation | $330.41 | 24 | $0 (2024) |
| Medtronic, Inc. | $203.06 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $195.47 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $136.02 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 1 | $0 (2023) |
| Dova Pharmaceuticals | $119.09 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,808 | 71 | Madrigal Pharmaceuticals ($48,472) |
| 2023 | $8,099 | 76 | ABBVIE INC. ($6,855) |
| 2022 | $169.33 | 6 | Novo Nordisk Inc ($96.81) |
| 2020 | $12.25 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12.25) |
| 2019 | $243.46 | 2 | Merck Sharp & Dohme Corporation ($124.37) |
| 2018 | $47.72 | 2 | Synergy Pharmaceuticals Inc ($24.03) |
| 2017 | $3,778 | 51 | Merck Sharp & Dohme Corporation ($3,049) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,903.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $125.24 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $73.06 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,903.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $131.58 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $136.90 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,903.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,613.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $146.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,903.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $148.82 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $79.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,903.00 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 618 | 808 | $274,719 | $80,734 |
| 2022 | 10 | 344 | 412 | $212,321 | $40,795 |
| 2021 | 9 | 240 | 377 | $217,369 | $35,902 |
| 2020 | 7 | 225 | 377 | $200,619 | $34,307 |
Total Patients
1,427
Total Services
1,974
Medicare Billing
$191,738
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 248 | $67,487 | $25,844 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $38,822 | $12,155 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 141 | 141 | $37,929 | $11,359 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 127 | $23,749 | $9,416 | 39.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $36,617 | $4,459 | 12.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 57 | $10,431 | $3,774 | 36.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $17,904 | $3,606 | 20.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 26 | $9,100 | $2,845 | 31.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $9,972 | $2,201 | 22.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,168 | $2,031 | 28.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $11,715 | $1,753 | 15.0% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 15 | 15 | $3,825 | $1,291 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 190 | $103,105 | $20,900 | 20.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 59 | $30,621 | $3,847 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 45 | $16,499 | $3,777 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 19 | $13,774 | $3,224 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $13,858 | $2,772 | 20.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $14,700 | $2,532 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $5,825 | $1,355 | 23.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $6,825 | $1,257 | 18.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 16 | $3,280 | $589.60 | 18.0% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 18 | 18 | $3,834 | $542.38 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 134 | $73,700 | $14,257 | 19.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 65 | $43,700 | $5,820 | 13.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 54 | $26,332 | $3,518 | 13.4% |
About Dr. Sonja Olsen, M.D
Dr. Sonja Olsen, M.D is a Internal Medicine healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124221882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonja Olsen, M.D has received a total of $74,158 in payments from pharmaceutical and medical device companies, with $61,808 received in 2024. These payments were reported across 209 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,473).
As a Medicare-enrolled provider, Olsen has provided services to 1,427 Medicare beneficiaries, totaling 1,974 services with total Medicare billing of $191,738. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location West Palm Beach, FL
- Active Since 06/08/2007
- Last Updated 01/30/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124221882
Products in Payments
- REZDIFFRA (Drug) $48,311
- MAVYRET (Drug) $19,664
- ZEPATIER (Drug) $2,979
- ZEPOSIA (Drug) $431.02
- INTERSTIM (Device) $203.06
- RESMETIROM (Drug) $161.57
- XIFAXAN (Drug) $144.24
- DIFICID (Drug) $140.33
- Viekira (Drug) $135.96
- Mavyret (Drug) $133.56
- REMICADE (Biological) $120.31
- Doptelet (Drug) $119.09
- OCALIVA (Drug) $107.66
- LifeVest (Device) $93.69
- ENTYVIO (Biological) $90.88
- LINZESS (Drug) $80.82
- STELARA (Biological) $75.16
- DUPIXENT (Biological) $68.48
- MOVIPREP (Drug) $57.87
- RINVOQ (Biological) $51.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Palm Beach
Dr. David Liporace, D.o, D.O
Internal Medicine — Payments: $203,201
Internal Medicine $203,201
Florencia Ziemke, M.d, M.D
Internal Medicine — Payments: $134,388
Internal Medicine $134,388
Mira Baron, Md, Cpi, MD, CPI
Internal Medicine — Payments: $68,606
Internal Medicine $68,606
David Selzer, M.d, M.D
Internal Medicine — Payments: $11,417
Internal Medicine $11,417
Dr. Gabriel Gemayel, Md, MD
Internal Medicine — Payments: $10,220
Internal Medicine $10,220
Dr. Mark Rattinger, Md, MD
Internal Medicine — Payments: $9,711
Internal Medicine $9,711